People on the Move
Glythera
Glythera, a biotech company which spun out of the UK’s Bath University in 2012, has made a series of senior appointments.
Nigel Burns has been made a non-executive director and Ian Evetts has become Commercial Director at the Newcastle-Upon-Tyne firm which develops antibody drug conjugates.
Burns has previously worked as senior VP of Cambridge Antibody Technology, non-executive director of Navion, Chair of Cell Medica, and founder of Nascient and SweetSpot Therapeutics.
Evetts has held senior strategic roles in the pharmaceutical industry, including MD of Atebion BDS, strategic advisor at Bionure, and a business development director at AstraZeneca.